Molecular testing in routine surgical pathology is becoming an important component of the workup of many different types of tumors. In fact, in some organ systems, guidelines now suggest that the ...
Proposed acquisition will add new anatomic pathology services, proprietary PCR tests and a national client base EL MONTE, Calif., December 22, 2025--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: ...
Laboratory tests play a critical part of the healthcare system. Ordering and billing for these tests, however, is not always cut-and-dry. Compliance with federal laws and rules (like the Clinical ...
Please provide your email address to receive an email when new articles are posted on . A clinical diagnostics company and biotech firm have announced a partnership to develop a blood-based tau ...
The Division of Genomic Diagnostics and Bioinformatics has selected GenomOncology's Pathology Workbench and GenomAnalytics to help scale their molecular pathology lab's test volume and analysis, ...
Driven by the rising global cancer burden, aging populations, and rapid adoption of AI-powered digital pathology, the ...
Anyone who has endured a COVID-19 test and then counted down the hours until the results arrived knows how important it is to the patient to shrink the wait, and reduce anxiety and time in ...
BRISBANE, Australia: Integrated drone logistics networks will soon be shuttling pathology samples from the Moreton Bay islands to Mater Pathology testing labs under a new partnership between Mater and ...
Waiting 72 hours to receive COVID-19 test results can feel like forever. To speed up that process for urgent, priority patients, eHealth NSW has partnered with Microsoft to use cloud technology and ...
Fulgent Genetics, Inc. FLGT recently entered into an agreement to acquire selected assets of Bako Diagnostics and to acquire StrataDx — two well-known pathology testing companies — in a combined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results